Currently out of the existing stock ratings of Ken Trbovich, 14 are a BUY (73.68%), 4 are a HOLD (21.05%), 1 are a SELL (5.26%).

Ken Trbovich

Work Performance Price Targets & Ratings Chart

Analyst Ken Trbovich works with a stock forecast success ratio of 52.78% fulfilled within 228.25 days on average. Previously, Ken Trbovich worked at JANNEY.

Ken Trbovich’s has documented 43 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ASRT, Assertio Therapeutics at 29-Aug-2018.

Wall Street Analyst Ken Trbovich

Analyst best performing recommendations are on CARA (CARA THERAPEUTIC).
The best stock recommendation documented was for CARA (CARA THERAPEUTIC) at 6/28/2017. The price target of $22 was fulfilled within 2 days with a profit of $4.95 (18.37%) receiving and performance score of 91.84.

Average potential price target upside

ASRT Assertio Therapeutics CARA Cara Therapeutic PCRX Pacira Pharmaceuticals FLXN Flexion Therapeutics

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

4

$2.96 (284.62%)

4

3 months 17 days ago

1/5 (20%)

$3.1 (344.44%)

184

Buy

4

$2.96 (284.62%)

6

5 months 18 days ago

1/5 (20%)

$1.66 (70.94%)

289

Hold

16

$14.89 (1341.44%)

52

4 years 8 months 13 days ago

1/5 (20%)

$4.76 (42.35%)

59

Hold

12

$9.09 (312.37%)

28

4 years 11 months 5 days ago

9/12 (75%)

$5.34 (9.39%)

50

Buy

40

5 years 7 months 23 days ago

1/9 (11.11%)

$6.64 (19.90%)

120

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Ken Trbovich?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?